Jian-kang Jiang

National Center for Advancing Translational Sciences

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Targeting AML-associated FLT3 mutations with a type I kinase inhibitor”.

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor

Journal of Clinical Investigation(2020)10.1172/jci127907

N/A

0.557DataRank · unranked

40 citations

Katelyn Melgar, Lyndsey Bolanos, Kathleen Hueneman, Morgan M. Walker, Jian-kang Jiang +15 more

Repurposing of lonafarnib as a treatment for SARS-CoV-2 infection

JCI Insight(2024)10.1172/jci.insight.182704

N/A

0DataRank · unranked

1 citations

Parker Irvin, Seung Bum Park, Hannah Ivester, Inna Ricardo-Lax, Madeleine Leek +18 more